📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NovaCardia

1.1 - Company Overview

NovaCardia Logo

NovaCardia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cardiovascular drug development and commercialization of novel small molecule drugs to improve care for patients with cardiovascular disease; a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NovaCardia

Concept Medical Logo

Concept Medical

HQ: United States Website
  • Description: Provider of medical devices for treating coronary and peripheral artery disease, including a polymer nano-carrier eluting coronary stent system, sirolimus-coated balloon catheters for coronary disease, a sirolimus coronary eluting stent for diabetic patients, and sirolimus drug-coated balloons for arteriovenous fistula and peripheral arteries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Concept Medical company profile →
HeartSciences Logo

HeartSciences

HQ: United States Website
  • Description: Provider of AI-based ECG technology, offering the MyoVista wavECG Device, a 12-lead resting electrocardiograph using wavelet signal processing and AI to detect cardiac dysfunction, including LV relaxation abnormalities; the MyoVista Energy Waveform, for visual context and assessing signal quality issues (not for clinical assessment); and the MyoVista wavECG LV Relaxation Algorithm indicating levels of LV relaxation abnormality.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HeartSciences company profile →
U.S. Stem Cell Logo

U.S. Stem Cell

HQ: United States Website
  • Description: Provider of regenerative medicine and autologous cellular therapies for degenerative conditions, offering in-clinic solutions and training for physicians, regenerative medicine solutions for veterinary patients, and collaboration with industry innovators on R&D of cell-based therapeutics aimed at repairing damaged tissue.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full U.S. Stem Cell company profile →
EPD Solutions Logo

EPD Solutions

HQ: Spain Website
  • Description: Provider of cardiac imaging and navigation systems, dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures to treat cardiac arrhythmias; a Dutch company and member of the Hobart Group companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EPD Solutions company profile →
CH Biomedical Logo

CH Biomedical

HQ: United States Website
  • Description: Provider of ventricular assist device (VAD) technology utilizing an innovative magnetic levitation pump design, including the CH-VAD®, an implantable left ventricular assist system using full magnetic levitation to support heart function in patients with end-stage heart failure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CH Biomedical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NovaCardia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NovaCardia

2.2 - Growth funds investing in similar companies to NovaCardia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NovaCardia

4.2 - Public trading comparable groups for NovaCardia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NovaCardia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NovaCardia

What does NovaCardia do?

NovaCardia is a provider of cardiovascular drug development and commercialization of novel small molecule drugs to improve care for patients with cardiovascular disease; a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.

Who are NovaCardia's competitors?

NovaCardia's competitors and similar companies include Concept Medical, HeartSciences, U.S. Stem Cell, EPD Solutions, and CH Biomedical.

Where is NovaCardia headquartered?

NovaCardia is headquartered in United States.

How many employees does NovaCardia have?

NovaCardia has 1,000 employees 🔒.

When was NovaCardia founded?

NovaCardia was founded in 2010 🔒.

What sector and industry vertical is NovaCardia in?

NovaCardia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NovaCardia

Who are the top strategic acquirers in NovaCardia's sector and industry

Top strategic M&A buyers and acquirers in NovaCardia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NovaCardia?

Top strategic M&A buyers groups and sectors for NovaCardia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NovaCardia's sector and industry vertical

Which are the top PE firms investing in NovaCardia's sector and industry vertical?

Top PE firms investing in NovaCardia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NovaCardia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NovaCardia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NovaCardia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NovaCardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NovaCardia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NovaCardia?

The key public trading comparables and valuation benchmarks for NovaCardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NovaCardia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NovaCardia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NovaCardia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NovaCardia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NovaCardia's' sector and industry vertical?

Access recent funding rounds and capital raises in NovaCardia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NovaCardia